Related references
Note: Only part of the references are listed.Don't you forget about me(gakaryocytes)
Julia Tilburg et al.
BLOOD (2022)
RUNX-1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cells
Brian Estevez et al.
BLOOD (2021)
TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis
Lilian Varricchio et al.
JCI INSIGHT (2021)
Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis
Brian D. Adair et al.
NATURE COMMUNICATIONS (2020)
A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling
Benjamin A. T. Rodriguez et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2020)
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML
Anna L. Brown et al.
BLOOD ADVANCES (2020)
The cis-Regulatory Atlas of the Mouse Immune System
Hideyuki Yoshida et al.
CELL (2019)
Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes
Valeria Santini et al.
CLINICAL CANCER RESEARCH (2019)
Targeting JNK pathway promotes human hematopoietic stem cell expansion
Xiong Xiao et al.
CELL DISCOVERY (2019)
Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia
Marcela Cavalcante de Andrade Silva et al.
CANCER GENETICS (2018)
A Multiplexed Screening Assay to Evaluate Chemotherapy-Induced Myelosuppression Using Healthy Peripheral Blood and Bone Marrow
Komal K. Javarappa et al.
SLAS DISCOVERY (2018)
DNMT1, a Novel Regulator Mediating mTORC1/mTORC2 Pathway-Induced NGF Expression in Schwann Cells
Meijuan Cheng et al.
NEUROCHEMICAL RESEARCH (2018)
Enhancing functional platelet release in vivo from in vitro-grown megakaryocytes using small molecule inhibitors
Danuta Jarocha et al.
BLOOD ADVANCES (2018)
Human NOTCH4 is a key target of RUNX1 in megakaryocytic differentiation
Yueying Li et al.
BLOOD (2018)
A view of human haematopoietic development from the Petri dish
Andrea Ditadi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Transforming growth factor β-inhibitor Repsox downregulates collagen expression of scleroderma dermal fibroblasts and prevents bleomycin-induced mice skin fibrosis
Maho Ide et al.
EXPERIMENTAL DERMATOLOGY (2017)
Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation
Rashmi Kanagal-Shamanna et al.
HAEMATOLOGICA (2017)
Defective acid hydrolase secretion in RUNX1 haplodeficiency: Evidence for a global platelet secretory defect
A. K. Rao et al.
HAEMOPHILIA (2017)
The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors
Emma Lefrancais et al.
NATURE (2017)
RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM)
Brigitte Schlegelberger et al.
SEMINARS IN HEMATOLOGY (2017)
The γ-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells
Paola Secchiero et al.
ONCOTARGET (2017)
Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation
Rashmi Kanagal-Shamanna et al.
HAEMATOLOGICA (2017)
FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology
Karen K. Vo et al.
BLOOD (2017)
Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults
Daria V. Babushok et al.
LEUKEMIA & LYMPHOMA (2016)
Identification of a potent small molecule capable of regulating polyploidization, megakaryocyte maturation, and platelet production
Nick Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia
Jane E. Churpek et al.
BLOOD (2015)
Comparative analysis of human ex vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary tale
Yuhuan Wang et al.
BLOOD (2015)
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia
Ileana Antony-Debre et al.
BLOOD (2015)
Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects
Jon P. Connelly et al.
BLOOD (2014)
Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets
A. C. Glembotsky et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Transcriptional Regulation and Its Misregulation in Disease
Tong Ihn Lee et al.
CELL (2013)
Transcription factors in late megakaryopoiesis and related platelet disorders
M. R. Tijssen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation
Hui Huang et al.
GENES & DEVELOPMENT (2012)
An image-based screen identifies a small molecule regulator of megakaryopoiesis
Anthony E. Boitano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Runx1 Loss Minimally Impacts Long-Term Hematopoietic Stem Cells
Xiongwei Cai et al.
PLOS ONE (2011)
Infusion of mature megakaryocytes into mice yields functional platelets
Rudy Fuentes et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome
M. C. J. Jongmans et al.
LEUKEMIA (2010)
High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder
Claude Preudhomme et al.
BLOOD (2009)
Modifying murine von Willebrand factor A1 domain for in vivo assessment of human platelet therapies
Jianchun Chen et al.
NATURE BIOTECHNOLOGY (2008)
Transcriptional control of megakaryocyte development
A. N. Goldfarb
ONCOGENE (2007)
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3
Richard M. Angell et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function
M Gaur et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis
M Ichikawa et al.
NATURE MEDICINE (2004)
Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors
W Sun et al.
BLOOD (2004)
Convulxin binds to native, human glycoprotein Ibα
S Kanaji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
